Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease — AngioPred  

Placental Vascular Pathologies Clinical Trial

Official title: Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease: Role of Angiogenic Factors, Hemostasis and Uterine Artery Doppler

Status Completed

Clinical Trial Summary

Venous thromboembolic (VTE) disease is the first cause of maternal mortality in the world. Some other pregnancy pathologies called Placental Vascular Pathologies (PVP) are linked to VTE by biological thrombophilia and are the principal cause of perinatal mortality. the identification of predictive factors of risk of occurrence or recurrence of two pathologies could enable us to propose an appropriate monitoring of patients at risk.

Clinical Trial Description

Main aim: To evaluate echographic, doppler and biological markers in a prospective manner as a potential predictive factor of risk of PVP and VTE. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Placental Vascular Pathologies
• Thromboembolism
• Venous Thromboembolism
• Venous Thromboembolism Diseases

• NCT number: NCT00695942
• Study type: Observational
• Source: Centre Hospitalier Universitaire de Saint Etienne
• Status: Completed
• Phase: N/A
• Start date: June 2008
• Completion date: May 2012